Publications by authors named "Yosuke Isa"

Article Synopsis
  • Dexamethasone, used as an antiemetic with cisplatin, is linked to muscle atrophy through the upregulation of specific muscle gene markers (MuRF1 and Atrogin-1) in a mouse model.* -
  • Research showed that when mice were treated with both cisplatin and dexamethasone, there was an increase in muscle atrophy markers and a decrease in muscle-promoting factors (myostatin and IGF-1). * -
  • The findings suggest that using dexamethasone alongside cisplatin may worsen muscle loss in cancer patients, highlighting a potential risk of this combined treatment.*
View Article and Find Full Text PDF

5-Fluorouracil (5-FU) is widely used as an anti cancer drug and is known to cause severe diarrhea. Recently we suggested that levels of chemokine (C-X-C motif) ligand 1 (CXCL1) and neutrophil recruitment in the colonic mucosa were drastically increased by the 5-FU administration in mice. Hange-shashin-to (HST) is prescribed in Japan for treat gastritis, stomatitis, and inflammatory diarrhea.

View Article and Find Full Text PDF

Cisplatin, a platinum-based anti-cancer drug, is one of the most effective broad-spectrum anti-cancer agents used against various cancers. It has been recently suggested that low skeletal muscle mass is predictive of mortality in patients with cancer. Although several molecules produced by the actual tumor itself contribute to skeletal muscle impairment, we recently suggested that the administration of cisplatin could increase levels of muscle RING finger-1 (MuRF1) and atrogin-1, possibly leading to muscle atrophy in the mouse.

View Article and Find Full Text PDF